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Mycoplasma infection is a well-known etiologic agent of
Stevens-Johnson syndrome (SJS)/toxic epidermal necroly-
sis (TEN). However, the effect of mycoplasma infection on
drug-induced hypersensitivity syndrome/ drug rash and
eosinophilia with systemic symptoms (DIHS/DRESS) has
not been clarified. We report a 25-year-old female sus-
pected of having DIHS/DRESS with a high fever and
erythematous eruption affecting the face, neck, and trunk.
Four weeks prior to skin rash, the patient had been
prescribed carbamazepine for epilepsy. On day 26 of her
medication use, the eruption began with erythema on her
neck, gradually worsening over the next 3 days. The
patient was admitted to our hospital under suspicion of
DIHS/DRESS. Her white blood cell count was 3900/L with
eosinophilia (13.9%). Liver function tests revealed an
increase in serum ALT and AST levels (ALT: 177 IU/L,
AST: 124 IU/L), and hypogammaglobulinemia was
detected (IgG: 939 mg/dL). The patient had experienced a
severe bout of coughing 10 days before admission, and
mycoplasma infection was confirmed based on an increase
in mycoplasma antibody titers. LTT was positive at an ear-
lier point (7th hospital day) than is typically observed with
DIHS/DRESS. Surprisingly, the patient rapidly recovered
after only discontinuation of carbamazepine administra-
tion. Our previous study demonstrated that regulatory
T (Treg) cells with suppressive function were expanded at
the acute stage of DIHS/DRESS, while functional defects
in Treg cells were detected in patients with SJS/TEN. We
therefore investigated whether Treg cells obtained from
this patient with an abortive form of DIHS/DRESS were
able to retain their suppressive capacity. Our findings
showed that Treg cells from our present patient were
profoundly defective in their ability to suppress T cell pro-
liferation, demonstrating that mycoplasma infection was
indeed able to suppress Treg function. In view of these
findings, we suggest that mycoplasma infection be deemed
a risk factor for developing SJS/TEN but be accepted as
important for inhibiting development of DIHS/DRESS.
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